Duration of Untreated Prodromal Psychosis and Cognitive Impairments
- PMID: 38277145
- PMCID: PMC10818213
- DOI: 10.1001/jamanetworkopen.2023.53426
Duration of Untreated Prodromal Psychosis and Cognitive Impairments
Abstract
Importance: The possible association between the duration of untreated prodromal symptoms (DUPrS) and cognitive functioning in individuals at clinical high risk (CHR) for psychosis remains underexplored.
Objective: To investigate the intricate interplay between DUPrS, cognitive performance, and conversion outcomes, shedding light on the potential role of DUPrS in shaping cognitive trajectories and psychosis risk in individuals at CHR for psychosis.
Design, setting, and participants: This cohort study of individuals at CHR for psychosis was conducted at the Shanghai Mental Health Center in China from January 10, 2016, to December 29, 2021. Participants at CHR for psychosis typically exhibit attenuated positive symptoms; they were identified according to the Structured Interview for Prodromal Syndromes, underwent baseline neuropsychological assessments, and were evaluated at a 3-year clinical follow-up. Data were analyzed from August 25, 2021, to May 10, 2023.
Exposure: Duration of untreated prodromal symptoms and cognitive impairments in individuals at CHR for psychosis.
Main outcomes and measures: The primary study outcome was conversion to psychosis. The DUPrS was categorized into 3 groups based on percentiles (33rd percentile for short [≤3 months], 34th-66th percentile for median [4-9 months], and 67th-100th percentile for long [≥10 months]). The DUPrS, cognitive variables, and the risk of conversion to psychosis were explored through quantile regression and Cox proportional hazards regression analyses.
Results: This study included 506 individuals (median age, 19 [IQR, 16-21] years; 53.6% [n = 271] women). The mean (SD) DUPrS was 7.8 (6.857) months, and the median (IQR) was 6 (3-11) months. The short and median DUPrS groups displayed poorer cognitive performance than the long DUPrS group in the Brief Visuospatial Memory Test-Revised (BVMT-R) (Kruskal-Wallis χ2 = 8.801; P = .01) and Category Fluency Test (CFT) (Kruskal-Wallis χ2 = 6.670; P = .04). Quantile regression analysis revealed positive correlations between DUPrS rank and BVMT-R scores (<90th percentile of DUPrS rank) and CFT scores (within the 20th-70th percentile range of DUPrS rank). Among the 506 participants, 20.8% (95% CI, 17.4%-24.5%) converted to psychosis within 3 years. Cox proportional hazards regression analysis identified lower educational attainment (hazard ratio [HR], 0.912; 95% CI, 0.834-0.998), pronounced negative symptoms (HR, 1.044; 95% CI, 1.005-1.084), and impaired performance on the Neuropsychological Assessment Battery: Mazes (HR, 0.961; 95% CI, 0.924-0.999) and BVMT-R (HR, 0.949; 95% CI, 0.916-0.984) tests as factors associated with conversion.
Conclusions and relevance: The finding of this cohort study suggest the intricate interplay between DUPrS, cognitive performance, and conversion risk in individuals at CHR for psychosis. The findings emphasize the importance of considering both DUPrS and cognitive functioning in assessing the trajectory of these individuals.
Conflict of interest statement
Figures



Similar articles
-
Duration of untreated prodromal psychosis among individuals with clinical high risk for psychosis.Psychiatry Res. 2023 Nov;329:115522. doi: 10.1016/j.psychres.2023.115522. Epub 2023 Oct 6. Psychiatry Res. 2023. PMID: 37812943
-
Duration of untreated prodromal symptoms in a Chinese sample at a high risk for psychosis: demographic, clinical, and outcome.Psychol Med. 2018 Jun;48(8):1274-1281. doi: 10.1017/S0033291717002707. Epub 2017 Nov 27. Psychol Med. 2018. PMID: 29173206
-
Relationship between duration of untreated prodromal symptoms and symptomatic and functional recovery.Eur Arch Psychiatry Clin Neurosci. 2019 Dec;269(8):871-877. doi: 10.1007/s00406-018-0917-z. Epub 2018 Jun 25. Eur Arch Psychiatry Clin Neurosci. 2019. PMID: 29942980
-
Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.JAMA Psychiatry. 2020 Jul 1;77(7):755-765. doi: 10.1001/jamapsychiatry.2019.4779. JAMA Psychiatry. 2020. PMID: 32159746
-
Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk: A Systematic Review and Meta-Analysis.JAMA Psychiatry. 2024 Jul 1;81(7):727-730. doi: 10.1001/jamapsychiatry.2024.0178. JAMA Psychiatry. 2024. PMID: 38506802 Free PMC article.
Cited by
-
Gender differences in neurocognitive impairment among first-episode, drug-naïve schizophrenia patients: a cross-sectional study.Front Psychiatry. 2025 Aug 4;16:1642291. doi: 10.3389/fpsyt.2025.1642291. eCollection 2025. Front Psychiatry. 2025. PMID: 40831523 Free PMC article.
-
The impact of aripiprazole on neurocognitive function in individuals at clinical high risk for psychosis: A comparison with olanzapine and non-antipsychotic treatment.Eur Psychiatry. 2025 May 22;68(1):e69. doi: 10.1192/j.eurpsy.2025.2459. Eur Psychiatry. 2025. PMID: 40401719 Free PMC article.
-
Cognitive impairments in first-episode psychosis patients with attenuated niacin response.Schizophr Res Cogn. 2025 Jan 27;40:100346. doi: 10.1016/j.scog.2025.100346. eCollection 2025 Jun. Schizophr Res Cogn. 2025. PMID: 39925786 Free PMC article.
-
Advancements and Future Directions in Prevention Based on Evaluation for Individuals With Clinical High Risk of Psychosis: Insights From the SHARP Study.Schizophr Bull. 2025 Mar 14;51(2):343-351. doi: 10.1093/schbul/sbae066. Schizophr Bull. 2025. PMID: 38741342 Free PMC article. Review.
-
Timeframe for Conversion to Psychosis From Individuals at Clinical High-Risk: A Quantile Regression.Schizophr Bull. 2025 Jul 7;51(4):1030-1041. doi: 10.1093/schbul/sbae129. Schizophr Bull. 2025. PMID: 39054751 Free PMC article.
References
-
- Stone WS, Cai B, Liu X, et al. Association between the duration of untreated psychosis and selective cognitive performance in community-dwelling individuals with chronic untreated schizophrenia in rural China. JAMA Psychiatry. 2020;77(11):1116-1126. doi: 10.1001/jamapsychiatry.2020.1619 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical